Literature DB >> 27221920

Post-Loop Electrosurgical Excision Procedure Complications in Srinagarind Hospital.

Pimjai Maleerat1, Bandit Chumworathayi, Chumnan Kietpeerakool, Sanguanchoke Luanratanakorn, Amornrat Temtanakitpaisan.   

Abstract

The purpose of this study was to evaluate the prevalence and predictors of post-Loop Electrosurgical Excision Procedure (LEEP) complications in Srinagarind Hospital, Khon Kaen, Thailand. Retrospective chart review was performed for 200 patients undergoing LEEP during January 2012 to February 2013. Their mean age was 45 years-old. Fifty-three (26.5%) were menopausal. The three most common preceding abnormal cervical cytology were high-grade squamous intraepithelial lesion (HSIL; 50%), atypical squamous cell cannot exclude HSIL (ASC-H; 10.5%), and low-grade squamous intraepithelial lesion (LSIL; 10%). The overall complications prevalence rate was 16.5% (95%CI, 11.4-21.6). Complications included bleeding (11%; 95%CI, 6.66-15.3), offensive discharge (4%; 95%CI, 1.28-6.72), and pelvic inflammatory disease (1.5%; 95%CI, 0.18-3.18). Only mode of delivery was an independent predictor of post-LEEP complications. Women with previous caesarean sections carried an increased risk of complications by 3.9 times (95%CI, 1.21-12.56) compared with vaginal delivery. In conclusion, LEEP is generally safe with an acceptable complication rate. Previous caesarean section was the only independent predictor for post-LEEP complications. However, this predictor still needs prudent evaluation as no clear cause-effect relationship was identified.

Entities:  

Mesh:

Year:  2016        PMID: 27221920     DOI: 10.7314/apjcp.2016.17.4.2211

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  1 in total

1.  Efficacy of a chitosan tampon in the loop electrosurgical excision procedure: A prospective randomized controlled study.

Authors:  Gun Oh Chong; Yoon Hee Lee; Se Young Jeon; Hee-Young Yang; Sang-Hyun An
Journal:  Sci Rep       Date:  2020-04-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.